Filing Details
- Accession Number:
- 0001209191-11-041602
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-29 16:38:11
- Reporting Period:
- 2011-07-29
- Filing Date:
- 2011-07-29
- Accepted Time:
- 2011-07-29 16:38:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227915 | Partnership Limited Gp Iii Ahls | C/O Advent International Corporation 75 State Street, 29Th Floor Boston MA 02109 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-07-29 | 5,069 | $14.61 | 2,629,377 | No | 4 | S | Indirect | see footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | see footnote |
Footnotes
- These securities are indirectly beneficially owned in the following capacity: as General Partner Advent Healthcare and Life Sciences III Limited Partnership and Advent Healthcare and Life Sciences III-A Limited Partnership.